Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience

BRILLIANT Working Group

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience'. Together they form a unique fingerprint.

Medicine & Life Sciences